Chairperson: J. Cunha-Vaz PORTUGAL
12.00 |
J. Cunha-Vaz PORTUGAL Anti-VEGF local treatment in high risk patients |
12.12 |
W. Mieler USA Systemic implications of anti-VEGF therapy |
12.24 |
TBC |
12.36 |
G. Williams USA Enzymatic vitreolysis |
12.48 |
Discussion |
13.00 |
End of session |
Chairperson: C. Pournaras SWITZERLAND
12.00 |
M. Rehak CZECH REPUBLIC Anoxia-hypoxia mediated intracellular mechanisms |
12.10 |
E. Rungger-Brändler SWITZERLAND Blood retinal barrier changes |
12.20 |
E. Stefánsson ICELAND Physics and physiology of macular edema |
12.30 |
B. Bodaghi FRANCE The role of inflammatory mediators |
12.40 |
C. Pournaras SWITZERLAND Cellular mechanisms of traction related macular edema |
12.50 |
Discussion |
13.00 |
End of session |
Chairperson: B. Corcóstegui SPAIN
Co-ordinators: D.E. Pelayes ARGENTINA; U. Schmidt-Erfurth AUSTRIA
Synopsis
Using intraoperative videos and case presentations, a panel of internationally recognised experts will demonstrate their approach to various types of vitreoretinal diseases. Clinical
evolution and diagnosis options will also be analysed, along with a review of the different management options employed by the panelists.
Objective
To familiarise participants with specific treatment recommendations and the management of unusual clinical and surgical vitreo retinal diseases.
14.00 |
J. Verdager CHILE Bilateral Diffuse Uveal Melanocytic Proliferation associated with renal cell carcinoma (BDUMP) |
14.09 |
F. Bandello ITALY Juxtafoveal choroidal neovascularisation secondary to persistent placoid maculopathy treated with intravitreal bevacizumab |
14.18 |
G. Gabela ECUADOR Intravitreal bevacizumab vs intravitreal triamcinolona diabetic macular edema |
14.27 |
S. Seregard SWEDEN Diffuse type retinoblastoma |
14.36 |
G. Richard GERMANY Long-term results after implantation of an epiretinal electrode array |
14.45 |
T. Wolfensberger SWITZERLAND Case Report |
14.54 |
M. Nahemy BRAZIL Oral and intravitreal voriconazole in the management of chronic fungal endophthalmitis |
15.03 |
B. Aylward UK Weird and wonderful retinal detachments |
15.12 |
A. Gaudric FRANCE Vitreoretinal surgery for VHL disease, video presentation |
15.21 |
Open discussion |
15.30 |
End of session |
E. Zrenner GERMANY
Can we overcome the fragmented European research space in ophthalmology?
B. Aylward VICE-PRESIDENT, EURETINA
Introduction
H. Lincoff USA
The detachment emanating from retinoschisis
I. Kreissig GERMANY
Presentation of AWARD
The following themes will be addressed in this session organised by the Retina Section of the EVI.CT.SE clinical trials network:
Chairperson: S. Lesnik-Oberstein THE NETHERLANDS
DEBATE 1: |
Small gauge surgery FOR: G. Williams USA |
DEBATE 2: |
All peripheral retinal lesions need treatment FOR: R. Tadayoni FRANCE |
Chairperson: E. Souied FRANCE
13.50 |
M. Goldstein ISRAEL, E. Souied FRANCE Welcome |
14.00 |
G. Coscas FRANCE OCT features of AMD |
14.20 |
AMD SESSION Moderators: E. Souied FRANCE, A. Lowenstein ISRAEL |
1. |
A. Lowenstein ISRAEL PHP |
2. |
S. Yves Cohen FRANCE One-year results of ranibizumab for exudative AMD in a clinical setting |
3. |
I. Chowers ISRAEL Clinical study in AMD |
4. |
G. Soubrane FRANCE Features of drusen using adaptative optics |
| Discussion | |
15.00 |
Break |
15.20 |
MEDICAL RETINA SESSION Moderators: B. Bodaghi FRANCE, M. Goldstein ISRAEL |
1. |
J. A. Sahel FRANCE Adaptive optics |
2. |
R. Zolf ISRAEL RPE RIP after anti-VEGF treatment for myopic CNV |
3. |
M. Paques FRANCE Toward novel classification of RVO |
4. |
B. Bodaghi FRANCE Viral retinopathies: Past, present and future |
5. |
M. Goldstein ISRAEL Fluorescein cases |
6. |
N. Benhamou ISRAEL Fluorescein cases |
16.15 |
SURGICAL RETINA SESSION Moderators: J.F. Korobelnik FRANCE, R. Siegal ISRAEL |
1. |
A. Alhalel ISRAEL War-related ocular trauma |
2. |
R. Tadayoni FRANCE Surgical drugs or instruments? Limits and interactions in vitreoretinal surgery |
| H. Desatnik ISRAEL Familial exudative vitreo-retinopathy |
|
3. |
R. Siegal ISRAEL Bevacizumab in ROP |
4. |
J.F. Korobelnik FRANCE Triamcinolone as a dye in vitreoretinal surgery |
|
Discussion |
17.00 |
M. Goldstein ISRAEL Closure |
Chairperson: V. Chong UK
All registered delegates at the EURETINA Congress are welcome to attend this session.
Those who wish to present should prepare a single case presentation and email an intention
of presenting to victor.chong@eye.ox.ac.uk
It is not necessary to submit the case before the Congress, but speakers should upload their presentation at the Speaker Check-In Room by 12.00 on Saturday 16 May.